NCT01559701View on ClinicalTrials.gov

Long-term Safety of PF-00345439 (Oxycodone)

PHASE3CompletedINTERVENTIONAL

Enrollment

823

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Pain

Interventions

DRUG

PF-00345439

5-80 mg twice-a-day for 12 months

Sponsors

Lead Sponsor

Pain Therapeutics

All Listed Sponsors

lead

Pain Therapeutics

INDUSTRY